CardioMech
Manufacturing · Norway · 1-10 Employees
View Company Info for Free
Overview
Headquarters
C/o Nikolai Hiorth Udbyes Gate 3a, Trond...Phone Number
+47 21546100Website
www.cardiomech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CardioMech
CardioMech is focused on designing innovative therapeutic options for heart disease, specifically targeting Mitral Regurgitation, a prevalent and serious cardiovascular condition. Their flagship product, the CardioMech MVRS, is a transcatheter mitral valve repair solution that aims to simplify procedures for patients, offering a less invasive alternative to traditional open-heart surgery. This device is intended for both patients eligible for surgery and those deemed surgically ineligible, potentially reducing the need for more invasive interventions. Currently, the CardioMech MVRS is in the investigational stage and is not available for sale.Explore more
CardioMech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CardioMech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when CardioMech launches new products
Check out if CardioMech is spiking on competitors!
Funding: Get notified immidiatlly once CardioMech has new funding data
Earning: See what the market has to say on CardioMech recently announced quarterly report
Click to see if CardioMech had a recent Job posting/layoffs
CardioMech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CardioMech
Website visits: Recent activity has been detected on your website
Check if CardioMech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CardioMech
Find 2 more new buyers
Company Profile Activity
Activity Insights
CardioMech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CardioMech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CardioMech.
CardioMech financials insights
Gather financial insights about CardioMech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Debt
$5M
2020
Series A
$18.5M
2024
Other Financing Round
$13M
CardioMech Tech Stack
A closer look at the technologies used by CardioMech
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Funding
Funding
Funding
CardioMech News & Media
Norway: Sustainable, data-driven, and digitally ambitious
Norway’s tech ecosystem is maturing quietly but confidently. With world-class digital infrastructure, strong public trust, and robust government support, the country is well-positioned to lead in sust...CARDIOMECH RAISES $13M IN HEAVILY OVERSUBSCRIBED ROUND FOR ITS TRANSCATHETER MITRAL CHORDAL REPAIR TECHNOLOGY
CardioMech received strong support by investors despite challenging environment because of its potential to be a category-defining Chordal Repair technology MINNEAPOLIS, Jan. 2, 2024 /PRNewswire/ -- Norway-based CardioMech AS, a medical device company developing a transfemoral,...CardioMech AS Announces $18.5M Series A for its Transcatheter Mitral Valve Repair Technology
The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech's journey to treat patients in a first-in-human feasibility trial MINNEAPOLIS, Aug. 5, 2020 /PRNewswire/ -- Minneapolis based CardioMech AS, a medical device company...CardioMech Raises $5M in Funding
CardioMech AS, an Oslo, Norway-based company developing a transcatheter mitral valve repair technology, closed on a convertible note financing of $5m. The note included investments from MedTech investors and brings the total amount raised for CardioMech to $7.5m in 2019. The company intends to use the funds to further accelerate the development of its technology. […] The post CardioMech Raises $5M in Funding appeared first on FinSMEs.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CardioMech
Sign Up For FreeTo access detailed company insights
CardioMech is focused on designing innovative therapeutic options for heart disease, specifically targeting Mitral Regurgitation, a prevalent and serious cardiovascular condition. Their flagship product, the CardioMech MVRS, is a transcatheter mitral valve repair solution that aims to simplify procedures for patients, offering a less invasive alter... Read More
